We carried out a meta-analysis of data from three genomewide association (GWA) studies of type 1 diabetes (T1D), testing 305,090 SNPs in 3,561 T1D cases and 4,646 controls of European ancestry. We obtained further support for 4q27 (IL2-IL21, P ¼ 1.9 Â 10 À8 ) and, after genotyping an additional 6,225 cases, 6,946 controls and 2,828 families, convincing evidence for four previously unknown and distinct risk loci in chromosome regions 6q15 (BACH2, P ¼ 4.7 Â 10 À12 ), 10p15 (PRKCQ, P ¼ 3.7 Â 10 À9 ), 15q24 (CTSH, P ¼ 3.2 Â 10 À15 ) and 22q13 (C1QTNF6, P ¼ 2.0 Â 10 À8 ).
In the present study, we undertook a meta-analysis of three GWA studies, combining the British Wellcome Trust Case Control Consortium (WTCCC) 1 T1D case-control data with 1,785 US T1D cases from the Genetics of Kidneys in Diabetes (GoKinD) study 2, 3 and 1,727 US controls from the National Institute of Mental Health (NIMH). All samples were genotyped using the Affymetrix 500K SNP chipset, but each study used a different scoring algorithm, potentially introducing a differential bias in genotype calling between US cases and controls and resulting in false-positive associations 4 . Consequently, we started the analysis by rescoring the US case-control data (Supplementary Methods online).
After rescoring the US case-control data, for consistency between the studies, we also updated the WTCCC and NIMH SNP information to NCBI Human Genome build 36 and aligned the SNP alleles between studies. We then applied SNP and sample quality control filters to each study (Supplementary Methods). After application of clustering quality and minimum minor allele frequency filters, 330,183 WTCCC and 335,565 GoKinD-NIMH SNPs remained. We note that inspection of allele signal intensity plots was still required for the GoKinD-NIMH SNPs (Supplementary Methods). For sample quality control, we excluded duplicate samples, first-or second-degree relatives, samples with low heterozygosity and samples with substantial non-European ancestry (all deduced from genotypes, Supplementary Methods), leaving 3,561 cases (1,960 British and 1,601 American) and 4,646 controls (2,942 British and 1,704 American).
We analyzed the US case-control data separately in order to gauge their quality and suitability for inclusion in the meta-analysis. To control for population structure within the US data, we used a propensity score derived from principal components (Supplementary Methods), which reduced the inflation of the test statistic from 18% to 14%. We convincingly detected (least significant P ¼ 9.2 Â 10 À4 ) eight of the ten confirmed T1D-associated regions 5 Fig. 1 online) , we did find additional support for the previously detected but unconfirmed 5 4q27 (IL2-IL21) region at P ¼ 4.8 Â 10 À3 (Supplementary Table 2 online).
We then carried out a meta-analysis of the evidence for 305,090 SNPs available in both the British and US studies. To produce an overall score test for these SNPs, we summed the score statistics and score variances from the British and US case-control analyses. As expected, the meta-analysis was dominated by known T1D-associated regions (Supplementary Table 1 and Supplementary Fig. 1 ); the test statistic inflation was 12% ( Supplementary Fig. 2 online) . Despite very different population backgrounds (Great Britain versus United States) and ascertainment (cases from pediatric T1D clinics versus longstanding T1D cases with or without diabetic nephropathy), there was no evidence of heterogeneity in the ten previously established T1D loci (Supplementary Table 1 ). The combined evidence for 4q27 (IL2-IL21) was P ¼ 1.9 Â 10 À8 , indicating that this is a true T1D locus (Supplementary Table 2) .
Although no new T1D loci were associated at genome-wide levels of significance, we followed up the most associated SNPs by genotyping an additional 6,225 case and 6,946 control samples from Great Britain. We removed the known T1D loci and SNPs with an r 2 Z 0.1 with them, and shortlisted the top 30 ranked SNPs (least significant P ¼ 1.2 Â 10 À5 ; P ¼ 3.4 Â 10 À5 corrected for 12% inflation) for follow-up (Supplementary Table 3 online). A further 11 SNPs from 12q24 and five SNPs from 1p13 were removed, as their associations were explained by known T1D-associated SNPs rs3184504 (SH2B3; ref. 5) (Supplementary Methods) and rs2476601 (PTPN22; ref. 6), respectively. A SNP, rs947474 (PRKCQ), on 10p15 which was 260 kb centromeric to the T1D-associated IL2RA region 7 proved to be independently associated by regression analysis (Supplementary Table 4 online) and separated by a number of recombination hot spots ( Supplementary Fig. 3 online) . In addition, we note that we were unable to find any evidence of an extended haplotype connecting the IL2RA region with rs947474 in PRKCQ (data not shown). A further four SNPs, despite passing SNP quality control filters (Supplementary Methods), were excluded after inspection of the genotype signal intensity plots (Supplementary Table 3 ). As four of the remaining ten SNPs were from 6q15 (BACH2), we genotyped seven SNPs for the follow-up analyses ( Table 1) .
We obtained additional support for four of the seven associations: rs11755527 (BACH2) on 6q15 (P ¼ 6.9 Â 10 À7 ; OR for minor allele G ¼ 1.13); rs947474 (PRKCQ) on 10p15 (P ¼ Table 1 ). In addition, we re-genotyped the seven SNPs in a minimum of 1,771 case and 2,756 control samples used in the WTCCC to validate the genotyping, which showed that concordance was 99.3% or better.
We also genotyped the four most associated SNPs (rs11755527, Table 1 ). The overall combined P values (2.0 Â 10 À8 to 3.2 Â 10 À15 ; Table 1 ) provided convincing support for four previously undetected and distinct T1D loci.
There are several interesting functional candidate genes located within the four newly associated regions (Supplementary Methods). The 365-kb associated region on 6q15 contains only one gene, BACH2, intron 3 of which contains rs11755527. BACH2 encodes BTB and CNC homology 1, basic leucine zipper transcription factor 2, which has a role as key regulator of nucleic acid-triggered antiviral responses in human cells 8 and is highly expressed in B cells 9 (GNF SymAtlas 10 ; Supplementary Fig. 4 online) . In the 234-kb associated region of 10p15, the gene encoding protein kinase C, theta (PRKCQ) is 79 kb telomeric to rs947474 (Supplementary Fig. 3 ). PRKCQ controls several fundamental processes in T-cell biology, including integration of T-cell receptor (TCR) and CD28 signaling, leading to activation of transcription factors (NF-B and AP-1) 11 . PRKCQdeficient mice have defects in the differentiation of T helper subsets, particularly in Th2-and Th17-mediated inflammatory responses 11 . Furthermore, its selective role in T-cell effector function makes PRKCQ an attractive therapeutic target in T cell-mediated disease processes 12 .
In the 660-kb associated region of 15q24, rs3825932 is located in intron 1 of CTSH (cathepsin H); the region also contains eight other genes ( Supplementary Fig. 5 online) . On 22q13, rs229541 is located between C1QTNF6 (C1q and tumor necrosis factor related protein 6) and SSTR3 (somatostatin receptor 3) in a 125-kb associated region that contains two other genes ( Supplementary Fig. 6 online) . The meta-analysis results suggest that coding and intronic sequences of the strong candidate gene IL2RB, 56 kb centromeric to rs229541, are not associated with T1D, as we previously reported 5 , although causal variants could affect the function of regulatory sequences that control the expression of genes hundreds of kilobases away.
To conclude, we present convincing evidence for four previously undetected and distinct T1D risk loci (6q15, BACH2; 10p15, PRKCQ; 15q24, CTSH and 22q13, C1QTNF6). In addition, we provide further support for 4q27 (IL2-IL21), increasing the total of T1D loci with convincing evidence from 10 (refs. 5,13,14) to 15 (including the HLA region). The evidence for these new T1D loci was obtained by forming a US case-control GWA study from existing data and incorporating this data into a meta-analysis with the British (WTCCC) data, followed by independent replication in cases and Table 1 Summary of results for the seven most associated SNPs found in the meta-analysis and followed up in additional samples Chr.
Gene region SNP MAF in British controls We report the maximum number of case, control and family samples with genotype data. The MAF was estimated in a minimum of 9,647 controls from the British 1958 Birth Cohort and UK Blood Services. The signal intensity plots are shown in Supplementary Figure 7 online. We report a 2-d.f. test when there was a significant difference between the genotypic effects model and the multiplicative allelic effects model. The SNP genotypes are reported in Supplementary Table 5 online. We used one-tailed tests for the family data (that is, the null hypothesis was not rejected unless the effect was in the same direction as the original study). a
The most associated BACH2 SNP was rs619192 (meta-analysis P value ¼ 3.98 Â 10 À6 ), which was in perfect linkage disequilibrium (r 2 ¼ 1) with rs11755527, genotyped based on an initial meta-analysis. N/A, not attempted. 15 .
In the current study, we have demonstrated the effectiveness of combining evidence from GWA studies to find disease loci with typical effect sizes (OR o 1.2), and shown that GWA studies can be successfully formed using case and control data from different studies, provided that allele signal intensity data are available for recalling and checking the SNP genotypes.
Note: Supplementary information is available on the Nature Genetics website.
